Australian Subsidiary
Working in conjunction with Rivermark Medical, the Board of Directors of each Australian subsidiary is responsible for the oversight, governance, and management of clinical trial activities conducted in Australia by its respective entity.
Directors
Mario Pennisi AM
Adam Kadlec MD
Address
Suite 1, Level 3, 62 Lygon Street, Carlton South VIC 3053
Mario G Pennisi AM
Mario is a respected Australian based company director, advocate and strategic advisor in the life sciences arena. Mario has held executive leadership roles in large commercial health companies including Mayne Health, as well CEO of the Qld Clinical Trials Network before going on to establish and lead the peak industry body, Life Sciences Queensland.
He has served for several years as an Adj Assoc Prof for the Centre for Clinical Research at University of Queensland and as Chair of the Griffith University Clinical Trials Unit Advisory Board.
Along with his role at Rivermark Medical Australia Pty Ltd, he is a consultant with Acclime Australia and provides Resident Director services for some of their portfolio companies.
He is currently also a Director of the Queensland Eye Institute Foundation, BrizBrain & Spine, and a member of the FaBA Advisory Committee.
He was made a Member of the Order of Australia in 2020, for significant service to the biomedical sector, to commercialization initiatives and to research.